Sunshine Biopharma Q1 EPS $(2.00) Misses $(1.04) Estimate, Sales $7.54M Beat $7.00M Estimate
Sunshine Biopharma Q1 EPS $(2.00) Misses $(1.04) Estimate, Sales $7.54M Beat $7.00M Estimate
阳光生物制药第一季度每股收益美元（2.00）未达到预期（1.04）美元，销售额754万美元超过700万美元的预期
Sunshine Biopharma (NASDAQ:SBFM) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of $(1.04) by 92.31 percent. This is a 75 percent increase over losses of $(8.00) per share from the same period last year. The company reported quarterly sales of $7.54 million which beat the analyst consensus estimate of $7.00 million by 7.73 percent. This is a 54.08 percent increase over sales of $4.89 million the same period last year.
阳光生物制药（纳斯达克股票代码：SBFM）公布的季度亏损为每股2.00美元，比分析师普遍预期的1.04美元（1.04美元）低92.31％。这比去年同期每股亏损8.00美元（8.00）增长了75％。该公司公布的季度销售额为754万美元，比分析师普遍预期的70万美元高出7.73％。这比去年同期的489万美元销售额增长了54.08％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。